Why the study?
Suxiao Jiuxin Pills were widely used to treat angina pectoris and atrial arrhythmia, but whether they regulate Kv1.5 channels was unclear.
Does Suxiao Jiuxin Pills inhibit hKv1.5 potassium channel currents in CHO cells?
Does Suxiao Jiuxin Pills inhibit hKv1.5 potassium channel currents in CHO cells?
Suxiao Jiuxin Pills block the human Kv1.5 potassium channel in a dose-, time-, and voltage-dependent manner, providing a mechanistic basis for its use in atrial arrhythmias.
Supports preclinical ion channel studies of herbal remedies; leaves open clinical relevance for arrhythmia management.
Kv1.5 channel plays key roles in cardiac action potential and atrial repolarization. Suxiao Jiuxin Pills (SXJ), an herbal remedy had been widely used in China in treating angina pectoris and atrial arrhythmia. However, whether SXJ regulates Kv1.5 channels is still unclear. The goal of the present study was to examine the effects of SXJ on cloned human potassium channels (hKv1.5) in Chinese hamster ovary (CHO) cells. The ionic and gating currents were detected; dose-dependent curve, current-voltage curve, steady-state activation curve (SSA), activation time constant (τ act ), deactivation (τ deact ), and gating currents were compared between SXJ and control. Further, intracellular application of SXJ was implemented. Results showed that SXJ inhibited the hKv1.5 current in a time-, dose- and voltage-dependent manner with a half maximal inhibitive concentration (IC 50 ) value of 38.85 milligram per liter. The voltage dependence was described by an equivalent electrical distance δ of 0.15, which suggested that at the binding site SXJ experienced 15% of the applied transmembrane electrical field. There were no significant different changes of SSA, τ act , τ deact , ‘On’ gating current (on- I g ), and ‘off’ gating current (off- I g ) between SXJ and Control ( P > 0.05). Intracellular application of SXJ could block the hKv1.5 current significantly ( P < 0.05). In conclusion, SXJ produces a dose-, time-, and voltage-dependent block of hKv1.5, with interacting electrical distance δ of 0.15. SXJ did not influence the gating currents and deactivation time course. SXJ was an open-blocker, which provided the experimental research of SXJ in clinical treating atrial arrhythmia.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: